bluebird bio, Inc. - BLUE Operatsion marja

bluebird bio, Inc. - BLUE emitenti grafik logotipi

Sog'liqni saqlash sektorining yuqori makro-barqarorligi bu yerda bluebird bio, Inc. (BLUE) uchun murakkab logistika xarajatlari va ishlab chiqarish to'siqlari bilan birga kelmoqda. Operatsion marja tendentsiyasi joriy resurslarni boshqarish samaradorligini namoyish etadi, bunda -202.50 ushbu ko'rsatkichning bugungi qiymatini ifodalaydi. Irsiy qon patologiyalari bo'lgan bemorlar uchun to'liq davolash imkoniyatini beruvchi gen terapiyasi sohasidagi noyob ishlanmalar muvaffaqiyatning asosini tashkil etadi.

bluebirdbio.com (BLUE): Operatsion foyda bo'yicha sotuv rentabelligi 04.07.2022dan 07.06.2025gacha

BLUE (bluebird bio, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

Kompaniyaning jamlanma tahlili:BLUE, Bluebird Bio
bluebird bio, Inc brendining mahsuloti

FDA ning qat'iy tartibga soluvchi tizimi doirasida eksklyuziv gen terapiyasi patentlariga ega bo'lgan bluebird bio, Inc. (BLUE) uchun joriy operatsion marja uning texnologik ustunligini monetizatsiya qilish ko'rsatkichi bo'lib xizmat qiladi. Ushbu koeffitsient operatsion daromadning tushumga nisbati sifatida hisoblanadi va soliqlar hamda foiz to'lovlarigacha bo'lgan asosiy faoliyatdan olingan sof daromad ulushini ko'rsatadi, bu esa biznesning ichki samaradorligini va bozorning tez-tez uchraydigan tebranishlariga nisbatan barqarorligini baholash imkonini beradi.

Muhim raqobatchilar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|Sotuvning operatsion marjasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Operatsion marja|Boundless Bio Inc. (BOLD) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi XCUR (exicuretx.com)|Imunon Inc - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja PHIO (Phio Pharmaceuticals Corp)|Operatsion foyda normasi MBIO|RNAZ - Operatsion rentabellik|Operatsion foyda normasi BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operatsion rentabellik|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik